Understanding daytime functioning in insomnia: responder and correlation analyses in patients treated with daridorexant

被引：0
|
作者：
Pierre-Philippe Luyet
Antonio Olivieri
Guy Braunstein
机构：
[1] Idorsia Pharmaceuticals Ltd,
来源：
Sleep Science and Practice | / 7卷 / 1期
关键词：
Clinically meaningful improvement; IDSIQ; Insomnia; Responders; Daytime functioning; Responder analysis; Total sleep time; Sleep quality;
D O I：
10.1186/s41606-023-00089-x
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 16 条
  • [1] EFFECTS OF DARIDOREXANT ON SLEEP AND DAYTIME FUNCTIONING IN OLDER PATIENTS WITH INSOMNIA DISORDER
    Fietze, I.
    Bassetti, C.
    Mayleben, D.
    Gimona, A.
    Pain, S.
    Kinter, D. Seboek
    [J]. SLEEP MEDICINE, 2022, 100 : S117 - S118
  • [2] Daridorexant is Efficacious in Improving Sleep as Well as Daytime Functioning in Insomnia Patients
    Kinter, Dalma Seboek
    Mayleben, David
    Fietze, Ingo
    Zammit, Gary
    Bassetti, Claudio
    Leger, Damien
    Post, Anke
    Pain, Scott
    Roth, Thomas
    Mignot, Emmanuel
    [J]. NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 136 - 137
  • [3] DARIDOREXANT IS SAFE AND IMPROVES BOTH SLEEP AND DAYTIME FUNCTIONING IN ELDERLY PATIENTS WITH INSOMNIA
    Fietze, Ingo
    Bassetti, Claudio
    Mayleben, David
    Gimona, Alberto
    Pain, Scott
    Kinter, Dalma Seboek
    [J]. SLEEP, 2021, 44 : A138 - A139
  • [4] EFFECTS OF DARIDOREXANT ON SLEEP AND DAYTIME FUNCTIONING IN OLDER ADULTS WITH INSOMNIA
    Fietze, Ingo
    Bassetti, Claudio
    Mayleben, David
    Gimona, Alberto
    Pain, Scott
    McCall, William
    Kinter, Dalma Seboek
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (04): : S69 - S70
  • [5] EFFICACY OF LONG-TERM TREATMENT WITH DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER ON SLEEP AND DAYTIME FUNCTIONING: A POST-HOC ANALYSIS
    Dauvilliers, Y.
    Benes, H.
    Garcia-Borreguero, D.
    Kunz, D.
    Plazzi, G.
    Thein, S.
    Coloma, P.
    Rausch, M.
    Sassi-Sayadi, M.
    Kinter, D. Seboek
    [J]. SLEEP MEDICINE, 2022, 100 : S119 - S119
  • [6] Novel evaluation of task participation diary as a metric for daytime functioning in insomnia patients
    Bickley, K.
    Lack, L.
    Lovato, D. N.
    [J]. JOURNAL OF SLEEP RESEARCH, 2019, 28
  • [7] Daridorexant, a novel dual orexin receptor antagonist, delivers significant improvement in sleep parameters and daytime function for patients with insomnia disorder
    Roth, T.
    Zammit, G.
    Mignot, E.
    Leger, D.
    Bassetti, C.
    Pain, S.
    Kinter, D. Seboek
    [J]. JOURNAL OF SLEEP RESEARCH, 2020, 29 : 152 - 152
  • [8] Eszopiclone efficacy and daytime functioning in non-elderly and elderly patients with chronic insomnia
    Scharf, M
    Rosenberg, R
    Zammit, G
    Roach, J
    [J]. SLEEP, 2004, 27 : 258 - 258
  • [9] Relationship Between Daytime Functioning and Fatigue Over 6 Months in Lemborexant-Treated Subjects with Insomnia Disorder
    Chepke, Craig
    Yardley, Jane
    Pinner, Kate
    Lundwall, Christie
    Moline, Margaret
    [J]. NEUROLOGY, 2023, 100 (17)
  • [10] Daytime functioning in older patients suffering from chronic insomnia: Treatment outcome in a randomized controlled trial comparing CBT with Zopiclone
    Omvik, Siri
    Sivertsen, Borge
    Pallesen, Stale
    Bjorvatn, Bjorn
    Havik, Odd E.
    Nordhus, Inger Hilde
    [J]. BEHAVIOUR RESEARCH AND THERAPY, 2008, 46 (05) : 623 - 641
12